UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000026614
Receipt No. R000030567
Scientific Title Risk factor analysis for postoperative nausea and vomiting in patients undergoing transcatheter aortic valve implantation.
Date of disclosure of the study information 2017/03/20
Last modified on 2020/03/23 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Risk factor analysis for postoperative nausea and vomiting in patients undergoing transcatheter aortic valve implantation.
Acronym Risk factor analysis for postoperative nausea and vomiting in patients undergoing transcatheter aortic valve implantation.
Scientific Title Risk factor analysis for postoperative nausea and vomiting in patients undergoing transcatheter aortic valve implantation.
Scientific Title:Acronym Risk factor analysis for postoperative nausea and vomiting in patients undergoing transcatheter aortic valve implantation.
Region
Japan

Condition
Condition postoperative nausea and vomiting
Classification by specialty
Surgery in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of this study is to identify the risk factors for PONV undergoing TAVI.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Postoperative nausea and vomiting within 24h after surgery
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who performed tranfemoral TAVI between January 2016 and February 2017 under general anesthesia in Osaka City University Hospital.
Key exclusion criteria Patients who could not be extubeted in the operating room.
Target sample size 70

Research contact person
Name of lead principal investigator
1st name Tokihiro
Middle name
Last name Yamada
Organization Osaka City University Graduate School of Medicine
Division name Anesthesiology
Zip code 5458586
Address 1-5-7, Asahimachi, Abeno-ku, Osaka 545-8585 Japan
TEL 06-6645-2186
Email anesth@med.osaka-cu.ac.jp

Public contact
Name of contact person
1st name Takashi
Middle name
Last name Juri
Organization Osaka City University Graduate School of Medicine
Division name Anesthesiology
Zip code 5458586
Address 1-5-7, Asahimachi, Abeno-ku, Osaka 545-8585 Japan
TEL 06-6645-2186
Homepage URL
Email anesth@med.osaka-cu.ac.jp

Sponsor
Institute Osaka City University Graduate School of Medicine
Institute
Department

Funding Source
Organization Osaka City University Graduate School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics Committee of Osaka City University Graduate School of Medicine
Address 1-5-7, Asahimachi, Abeno-ku, Osaka 545-8586 Japan
Tel 81-6-6646-6125
Email ethics@med.osaka-cu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪市立大学病院(大阪府)

Other administrative information
Date of disclosure of the study information
2017 Year 03 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 01 Month 31 Day
Date of IRB
2017 Year 03 Month 01 Day
Anticipated trial start date
2017 Year 03 Month 01 Day
Last follow-up date
2018 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We collect data related to postoperative nausea and vomiting from perioperative records of patients who performed TAVI. Multiple logistic regression analysis are performed using them.

Management information
Registered date
2017 Year 03 Month 20 Day
Last modified on
2020 Year 03 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030567